Published in

Wiley, Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 4S_Part_17(6), 2010

DOI: 10.1016/j.jalz.2010.05.1710

Oxford University Press (OUP), Mutagenesis, 6(22), p. 371-379

DOI: 10.1093/mutage/gem029

Links

Tools

Export citation

Search in Google Scholar

Buccal micronucleus cytome biomarkers may be associated with Alzheimer's disease

Journal article published in 2007 by Jane Hecker, Jeffrey Faunt, Philip Thomas, Michael Fenech
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Alzheimer's disease (AD) is a progressive degenerative disorder of the brain and is the commonest form of dementia. A buccal cytome assay was used to measure ratios of buccal cell populations and micronuclei in clinically diagnosed Alzheimer's patients compared to age and gender-matched controls. Frequencies of basal cells (P